Literature DB >> 8221425

Periodic health examination, 1993 update: 3. Periodontal diseases: classification, diagnosis, risk factors and prevention. Canadian Task Force on the Periodic Health Examination.

A I Ismail1, D W Lewis.   

Abstract

OBJECTIVE: To review the 1979 Canadian Task Force on the Periodic Health Examination recommendations on the diagnosis and prevention of periodontal disease. OPTIONS: Self-care at home, professional care, treatment with antimicrobial agents and management of patients at high risk. OUTCOMES: Maintaining the gingiva, alveolar bone and periodontal ligament in a healthy state (absence of gingival bleeding and no loss of epithelial attachment). EVIDENCE: A literature search for articles published from 1980 to 1993 was conducted. Selected studies published before 1980 were also reviewed if there were no recent updates. Evidence was evaluated and classified as good, fair or poor according to the criteria of the task force. VALUES: The task force's evidence-based rules for recommendations were used. In addition, whenever feasible, and on the basis of advice from the reviewers and experts, recommendations were modified in the interest of maintaining oral health (e.g., dental flossing in children). BENEFITS, HARMS AND COSTS: The recommendations are not expected to increase the costs of preventing periodontal diseases for the general population. They could benefit dental patients and reduce costs because they are based on the periodontal needs of patients rather than on the current universal application approach.

Entities:  

Mesh:

Year:  1993        PMID: 8221425      PMCID: PMC1485890     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  106 in total

1.  Reliability of attachment loss measurements in a longitudinal clinical trial.

Authors:  A M Best; J A Burmeister; J C Gunsolley; C N Brooks; H A Schenkein
Journal:  J Clin Periodontol       Date:  1990-09       Impact factor: 8.728

Review 2.  The role of histopathology in the diagnosis and prognosis of periodontal diseases.

Authors:  I R Gillett; N W Johnson; M A Curtis; G S Griffiths; J A Sterne; R J Carman; J L Bampton; J M Wilton
Journal:  J Clin Periodontol       Date:  1990-11       Impact factor: 8.728

3.  Absence of bleeding on probing. An indicator of periodontal stability.

Authors:  N P Lang; R Adler; A Joss; S Nyman
Journal:  J Clin Periodontol       Date:  1990-11       Impact factor: 8.728

4.  Evaluating periodontal status of US employed adults.

Authors:  L J Brown; R C Oliver; H Loe
Journal:  J Am Dent Assoc       Date:  1990-08       Impact factor: 3.634

5.  The significance of alveolar bone in periodontal disease. A long-term observation in patients with cleft lip, alveolus and palate.

Authors:  U Brägger; S Nyman; N P Lang; T von Wyttenbach; G Salvi; E Schürch
Journal:  J Clin Periodontol       Date:  1990-07       Impact factor: 8.728

6.  Distribution of certain subgingival microbial species in selected periodontal conditions.

Authors:  E D Savitt; S S Socransky
Journal:  J Periodontal Res       Date:  1984-03       Impact factor: 4.419

7.  Localized juvenile periodontitis and generalized severe periodontitis: clinical findings.

Authors:  J A Burmeister; A M Best; K G Palcanis; F A Caine; R R Ranney
Journal:  J Clin Periodontol       Date:  1984-03       Impact factor: 8.728

Review 8.  Plaque and chronic inflammatory periodontal disease. A question of ecology.

Authors:  H N Newman
Journal:  J Clin Periodontol       Date:  1990-09       Impact factor: 8.728

9.  Periodontal disease and NIDDM in Pima Indians.

Authors:  R G Nelson; M Shlossman; L M Budding; D J Pettitt; M F Saad; R J Genco; W C Knowler
Journal:  Diabetes Care       Date:  1990-08       Impact factor: 19.112

10.  Clinical and microbiological effects of subgingival and gingival marginal irrigation with chlorhexidine gluconate.

Authors:  D L Jolkovsky; M Y Waki; M G Newman; J Otomo-Corgel; M Madison; T F Flemmig; S Nachnani; H Nowzari
Journal:  J Periodontol       Date:  1990-11       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.